Mitsubishi Tanabe Pharma Corporation reported earnings results for the first quarter ended June 30, 2019. For the quarter, the company has posted revenue of ¥98.1 billion against ¥105.3 billion a year ago. Operating profit was ¥9.6 billion against ¥19.3 billion a year ago. Net profit attributable to owners of the company ¥6.8 billion against ¥13.9 billion a year ago.

For the first half of 2019, the company expects revenue of ¥187.0 billion; operating profit of ¥5.0 billion and net profit attributable to owners of the company ¥4.0 billion.